Key considerations to cancer institute’s gen AI deployment
CIO
JUNE 6, 2024
The overhype of generative AI was unavoidable last year, yet despite all the distraction, unproven benefits, and potential pitfalls, Dana-Farber Cancer Institute CIO Naomi Lenane didn’t want to ban the technology outright. It allows for security, compliance, PII checks, and other guardrails to be built around it.
Let's personalize your content